Atea Pharmaceuticals Inc (AVIR)
EBITDA Growth
20.61%
Quarterly · Period ending:
AVIR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported20.61%period ending
Latest reported20.61%period ending
AVIR Quarterly EBITDA YoY % (-68.31% → 20.61%)
Year-over-year change
High-resolution chart · PNG
AVIR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 20.6055% | |
| -33.3314% | |
| -55.1484% | |
| -35.2764% | |
| -2.8475% | |
| 45.9449% | |
| 14.2001% | |
| -0.9915% | |
| -37.5668% | |
| -78.6783% | |
| -43.5176% | |
| -159.1283% | |
| 6.3134% | |
| 16.4107% | |
| -122.2478% | |
| 46.6066% | |
| -456.3736% | |
| -237.2057% | |
| 487.0285% | |
| -25.3234% | |
| 187.4787% | |
| 869.6285% | |
| 544.055% | |
| -368.1009% | |
| -169.2246% | |
| -68.3143% |